Press Release Archives - Page 3 of 4 - IRIS CAPITAL INVESTMENT

28 Jul 22

Spexis provides business update

ALLSCHWIL, Switzerland, July 28, 2022 – Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today provides a business update, including development programs’ progress and its efforts to secure funding for these projects. Cash position to finance operations extended into January 2023 Resources focused…

02 May 22

MAGNUM Secures Funding Facility

Sidney, May 2nd, 2022 – Magnum Secures Funding facility – $20 Million Facility by IRIS DOWNLOAD MAGNUM press release

21 Jan 22

ENERGISME has announced the establishment of a line of equity financing

Boulogne Billancourt, Jan 19, 2022 – ENERGISME has announced the establishment of a line of equity financing DOWNLOAD ENERGISME press release

21 Jan 22

THERANEXUS Publishes its cash position as of 31 december 2021

Lyon, Jan 13, 2022 – THERANEXUS publishes its cash position as of 31 december 2021. Implementation of a new equity line. DOWNLOAD THERANEXUS press release

28 Jul 21

CIBOX – Setting up a financing line of up to € 1.5 million to initiate the acceleration of development in electric mobility

Paris, May 21, 2021 – CIBOX announces the establishment of a financing line for a maximum amount of € 1.5 million to initiate the acceleration of development in electric mobility DOWNLOAD CIBOX press release

25 May 21

BOOSTHEAT announces new funding in the form of an Equity Line with IRIS, up to €10 million, renewable twice

Paris, May 21, 2021 – BOOSTHEAT announces new funding in the form of an Equity Line with IRIS, up to €10 million, renewable twice DOWNLOAD Boostheat press release

22 Mar 21

Hybrigenics announces the implementation of an equity financing line.

Paris, March 22, 2021 – Hybrigenics has prioritized funding proposed by the company IRIS solution that offers very attractive financial conditions, including the absence of commission and complete flexibility with the ability to terminate without charge to print at any time. These funds will allow, like a SPAC1, to seize…

19 Jan 21

Theranexus implements a new equity line of an amount of up to €8.4 million in total over 12 months

Lyon, 18 January 2021 – Theranexus, a biopharmaceutical company innovating in the treatment of neurologicaldiseases and pioneer in the development of drug candidates modulating the interaction between neurons and glialcells, presents an update on its activities and announces the strengthening of its financial visibilityfor the medium term.

22 Dec 20

Cerinnov Group announces the implementation of an equity line of an amount of €2 million

Cerinnov Group (code ISIN : FR0013178712 – mnémo : ALPCV), spécialiste de l’ingénierie robotique et des équipements industriels pour l’industrie de la céramique et du verre en France et à l’international, annonce ce jour la mise en place d’un financement en fonds propres d’un montant nominal maximum de 2…

28 Jul 20

Polyphor Strengthens financial flexibility with CHF 19.3 million equity-linked financing

Polyphor AG (SIX: POLN) today announced that it has entered into an equity-inked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over the period of two years. IRIS will receive Polyphor shares to be created from the Company’s conditional…

Press Release

Links